Table 3.
Ischemic stroke patient demographics and clinical variables by PHQ-9 score change at follow-up clinic visit.
| Entire Cohort | Stable/Improved PHQ-9* Score | Worse PHQ-9 Score | Univariate analysis P value | |
|---|---|---|---|---|
| N | 201 | 128 | 73 | |
| Age, mean ± SD | 61.82 ± 14.84 | 62.63 ± 15.66 | 60.40 ± 13.27 | 0.31 |
| Male sex | 116 (58%) | 54 (42%) | 31 (42%) | 1.0 |
| Race | ||||
| Non-Hispanic White | 94 (47%) | 62 (48%) | 32 (44%) | 0.47 |
| Non-Hispanic Black | 56 (28%) | 32 (25%) | 24 (33%) | |
| Hispanic | 35 (17%) | 21 (16%) | 14 (19%) | |
| Asian | 4 (2%) | 3 (2%) | 1 (1%) | |
| Unknown | 12 (6%) | 10 (8%) | 2 (3%) | |
| Marital Status | ||||
| Single | 40 (20%) | 27 (21%) | 13 (18%) | 0.82 |
| Married | 116 (58%) | 74 (58%) | 42 (57%) | |
| Divorced | 14 (7%) | 7 (5%) | 7 (10%) | |
| Widowed | 21 (10%) | 14 (11%) | 7 (10%) | |
| Unknown | 10 (5%) | 6 (5%) | 4 (5%) | |
| Employment Status | ||||
| Employed | 65 (32%) | 51 (40%) | 14 (19%) | <0.001 |
| Unemployed | 11 (6%) | 7 (6%) | 4 (6%) | |
| Retired | 59 (29%) | 39 (30%) | 20 (27%) | |
| Disabled | 14 (7%) | 3 (2%) | 11 (15%) | |
| Unknown | 52 (26%) | 28 (22%) | 24 (33%) | |
| Stroke Circulation Location | ||||
| Anterior or Both | 131 (65%) | 89 (70%) | 42 (58%) | 0.093 |
| Posterior | 70 (35%) | 39 (30%) | 31 (43%) | |
| Stroke Side | ||||
| Right or Bilateral | 109 (54%) | 63 (49%) | 46 (63%) | 0.077 |
| Left only | 92 (46%) | 65 (51%) | 27 (37%) | |
| NIHSS† on Hospital Admission | ||||
| Mild (Score 0–4) | 117 (58%) | 73 (57%) | 44 (60%) | 0.77 |
| Moderate (Score 5–15) | 70 (35%) | 44 (34%) | 26 (36%) | |
| Severe (Score 16–42) | 13 (6.5%) | 10 (8%) | 3 (4%) | |
| Unknown | 1 (0.5%) | 1 (1%) | 0 (0%) | |
| mRS‡ at Clinic Follow-Up | ||||
| 0–1 | 96 (48%) | 69 (54%) | 27 (37.5%) | 0.027 |
| ≥2 | 103 (52%) | 58 (46%) | 45 (62.5%) | |
| Use of Antidepressants | ||||
| On Antidepressant at Admission | 21 (10%) | 11 (9%) | 10 (14%) | 0.34 |
| Prescribed Antidepressant at Discharge | 18 (9%) | 10 (8%) | 8 (11%) | 0.26 |
| Continued Antidepressant at Discharge | 20 (10%) | 10 (8%) | 10 (14%) | |
| On Antidepressant at Follow up | 42 (21%) | 22 (17%) | 20 (27%) | 0.11 |
| Prescribed Antidepressant at Follow-Up | 36 (18%) | 15 (12%) | 21 (29%) | 0.004 |
*
Patient Health Questionnaire-9
†
National Institutes of Health Stroke Scale
‡
modified Rankin Scale